Astellas’ generic Myrbetriq defence knocked back again April 22, 2024 AutoBot News 0 The threat of low-cost competition in the US to Astellas’ Myrbetriq for urinary incontinence has moved a step closer after a court recommended denying an injunction on the launch of generics.